Cargando…

Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics

The revival of psychedelic research coincided and more recently conjoined with psychopharmacological research on how drugs affect moral judgments and behaviors. This article makes the case for a moral psychopharmacology of psychedelics that examines whether psychedelics serve as non-specific amplifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Langlitz, Nicolas, Dyck, Erika, Scheidegger, Milan, Repantis, Dimitris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365088/
https://www.ncbi.nlm.nih.gov/pubmed/34408677
http://dx.doi.org/10.3389/fpsyt.2021.680064
_version_ 1783738637065650176
author Langlitz, Nicolas
Dyck, Erika
Scheidegger, Milan
Repantis, Dimitris
author_facet Langlitz, Nicolas
Dyck, Erika
Scheidegger, Milan
Repantis, Dimitris
author_sort Langlitz, Nicolas
collection PubMed
description The revival of psychedelic research coincided and more recently conjoined with psychopharmacological research on how drugs affect moral judgments and behaviors. This article makes the case for a moral psychopharmacology of psychedelics that examines whether psychedelics serve as non-specific amplifiers that enable subjects to (re-)connect with their values, or whether they promote specific moral-political orientations such as liberal and anti-authoritarian views, as recent psychopharmacological studies suggest. This question gains urgency from the fact that the return of psychedelics from counterculture and underground laboratories to mainstream science and society has been accompanied by a diversification of their users and uses. We propose bringing the pharmacological and neuroscientific literature into a conversation with historical and anthropological scholarship documenting the full spectrum of moral and political views associated with the uses of psychedelics. This paper sheds new light on the cultural plasticity of drug action and has implications for the design of psychedelic pharmacopsychotherapies. It also raises the question of whether other classes of psychoactive drugs have an equally rich moral and political life.
format Online
Article
Text
id pubmed-8365088
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83650882021-08-17 Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics Langlitz, Nicolas Dyck, Erika Scheidegger, Milan Repantis, Dimitris Front Psychiatry Psychiatry The revival of psychedelic research coincided and more recently conjoined with psychopharmacological research on how drugs affect moral judgments and behaviors. This article makes the case for a moral psychopharmacology of psychedelics that examines whether psychedelics serve as non-specific amplifiers that enable subjects to (re-)connect with their values, or whether they promote specific moral-political orientations such as liberal and anti-authoritarian views, as recent psychopharmacological studies suggest. This question gains urgency from the fact that the return of psychedelics from counterculture and underground laboratories to mainstream science and society has been accompanied by a diversification of their users and uses. We propose bringing the pharmacological and neuroscientific literature into a conversation with historical and anthropological scholarship documenting the full spectrum of moral and political views associated with the uses of psychedelics. This paper sheds new light on the cultural plasticity of drug action and has implications for the design of psychedelic pharmacopsychotherapies. It also raises the question of whether other classes of psychoactive drugs have an equally rich moral and political life. Frontiers Media S.A. 2021-08-02 /pmc/articles/PMC8365088/ /pubmed/34408677 http://dx.doi.org/10.3389/fpsyt.2021.680064 Text en Copyright © 2021 Langlitz, Dyck, Scheidegger and Repantis. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Langlitz, Nicolas
Dyck, Erika
Scheidegger, Milan
Repantis, Dimitris
Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics
title Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics
title_full Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics
title_fullStr Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics
title_full_unstemmed Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics
title_short Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics
title_sort moral psychopharmacology needs moral inquiry: the case of psychedelics
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365088/
https://www.ncbi.nlm.nih.gov/pubmed/34408677
http://dx.doi.org/10.3389/fpsyt.2021.680064
work_keys_str_mv AT langlitznicolas moralpsychopharmacologyneedsmoralinquirythecaseofpsychedelics
AT dyckerika moralpsychopharmacologyneedsmoralinquirythecaseofpsychedelics
AT scheideggermilan moralpsychopharmacologyneedsmoralinquirythecaseofpsychedelics
AT repantisdimitris moralpsychopharmacologyneedsmoralinquirythecaseofpsychedelics